- The trend backdrop is active with a 15-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Volume is elevated versus the 13-week average, confirming attention.
- Activity pressure is constructive, supporting the smart-money activity read.
BODALCHEM
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Bodal Chemicals Limited · Basic Materials · Specialty Chemicals
Latest close
68.98 INR
-2.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 13.8% above the Trend Line and sits at 66.9% of its 52-week range. The latest completed week returned -2.4%, after a 18.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100.
Setup score
64
out of 100
Latest Close
68.98 INR
7 Aug 2026
1W Return
-2.4%
latest completed week
4W Return
18.7%
short-term follow-through
12W Return
1.7%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.4%
Latest completed week; four-week move 18.7%.
Indicator stack
63/32
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
26 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.8% above the Trend Line and sits at 66.9% of its 52-week range. The latest completed week returned -2.4%, after a 18.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6012-week average 0.74
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.60Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 18.7% over four weeks, 1.7% over 12 weeks, and 1.9% over one year. The current trend has remained active for 15 consecutive weeks.
Performance by holding period
Active trend streak15 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.32Latest activity-pressure read.
Pressure change-154.0%Four-week change in activity pressure.
Leadership15.34Latest relative-leadership reading.
RS change953.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value97/100Relative valuation strength. Underlying universe rank 4; rank 1 is best.
Quality64/100Profitability and accounting quality. Underlying universe rank 37; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework48/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 18.2x Price divided by trailing earnings.
- Price / sales
- 0.4x Market value relative to trailing revenue.
- EV / EBITDA
- 8.2x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 8.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 44.8% Gross profit retained from each unit of revenue.
- Operating margin
- 4.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 7.0% Free cash flow generated from revenue.
- Return on invested capital
- 3.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 15.1% Latest one-year revenue growth.
- EPS growth
- 158.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 108.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 8/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 26 relevant articles.
8 positive · 15 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.8%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+25.8%Week of 20 Mar.
Worst week-7.5%Week of 10 Jul.
Latest week-2.4%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks0
Modest losses7
Sharp losses7
Recent vol6.0%13-week weekly-return volatility.
Base vol5.9%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank12 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape60/100
Trend, activity pressure, participation, and risk combine to a 60/100 tape read.
Indicator analysis74/100Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 11/12.
Activity pressure 0.60; No reversal markers Factors72/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 26; Buyback Yield rank 27; Small Cap Core rank 8 SVQF48/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 814.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 26 relevant articles.
Bodal Chemicals Number of Employees 2026 | Employee Count & Headcount Data Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 68.98 INR | -2.4% | 60.61 INR | 70.18 INR | -0.32 | 15.34 | 2.0M | On |
| 31 Jul 2026 | 70.66 INR | 3.9% | 59.97 INR | 70.21 INR | -0.46 | 19.08 | 1.2M | On |
| 24 Jul 2026 | 68.02 INR | 6.0% | 59.41 INR | 70.20 INR | -0.52 | 17.59 | 667.1K | On |
| 17 Jul 2026 | 64.16 INR | 10.4% | 58.94 INR | 70.21 INR | -0.43 | 8.21 | 674.4K | On |
| 10 Jul 2026 | 58.12 INR | -7.5% | 58.56 INR | 70.25 INR | -0.12 | -1.80 | 637.2K | On |
| 3 Jul 2026 | 62.84 INR | -5.2% | 58.37 INR | 70.35 INR | 0.19 | 5.40 | 90.5K | On |
| 26 Jun 2026 | 66.29 INR | -6.2% | 58.01 INR | 70.44 INR | 0.51 | 11.77 | 0 | On |
| 19 Jun 2026 | 70.65 INR | 3.4% | 57.61 INR | 70.48 INR | 0.76 | 19.14 | 268.0K | On |
| 12 Jun 2026 | 68.31 INR | -4.1% | 57.07 INR | 70.49 INR | 0.99 | 17.32 | 59.5K | On |
| 5 Jun 2026 | 71.20 INR | 0.4% | 56.72 INR | 70.53 INR | 1.13 | 23.56 | 59.6K | On |
| 29 May 2026 | 70.90 INR | -4.3% | 56.33 INR | 70.50 INR | 1.28 | 22.21 | 1.4M | On |
| 22 May 2026 | 74.11 INR | 9.3% | 56.01 INR | 70.47 INR | 1.34 | 26.82 | 7.4M | On |
| 15 May 2026 | 67.82 INR | -7.3% | 55.58 INR | 70.42 INR | 1.29 | 16.50 | 1.5M | On |
| 8 May 2026 | 73.15 INR | 7.5% | 55.30 INR | 70.41 INR | 1.36 | 22.84 | 2.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.